Difficulty: Medium
Average Score: 88%
Practice
One of the following is FALSE in hemolytic disease of the newborn caused by Rh incompatibility
Correct answer
B
Rationale
In hemolytic disease of the newborn caused by Rh incompatibility, the correct answer is B) Never occur in first-born infant. Rh incompatibility occurs when an Rh-negative mother carries an Rh-positive fetus, leading to maternal antibodies attacking the fetal red blood cells. This process typically happens in subsequent pregnancies, not in the first-born infant.
Option A is incorrect because the infant being Rh positive is a characteristic of Rh incompatibility. Option C is correct as maternal antibody titers can indeed help predict the severity of fetal disease by indicating the level of maternal sensitization. Option D is also correct as severe anemia is a common consequence of hemolytic disease of the newborn due to the destruction of red blood cells.
In an educational context, understanding hemolytic disease of the newborn is crucial for pediatric clinical nurse specialists as it impacts the care of newborns at risk. Recognizing the false statement helps in accurate assessment and intervention planning for infants affected by Rh incompatibility. This knowledge ensures appropriate monitoring and treatment to prevent complications associated with hemolytic disease.
Option A is incorrect because the infant being Rh positive is a characteristic of Rh incompatibility. Option C is correct as maternal antibody titers can indeed help predict the severity of fetal disease by indicating the level of maternal sensitization. Option D is also correct as severe anemia is a common consequence of hemolytic disease of the newborn due to the destruction of red blood cells.
In an educational context, understanding hemolytic disease of the newborn is crucial for pediatric clinical nurse specialists as it impacts the care of newborns at risk. Recognizing the false statement helps in accurate assessment and intervention planning for infants affected by Rh incompatibility. This knowledge ensures appropriate monitoring and treatment to prevent complications associated with hemolytic disease.